RVTY

#730
Revvity, Inc. Common Stock
104.5 2 USD
+2.09%
Sektör: Sağlık Hizmetleri
Baz: USD
Kar Para Birimi: USD
Günlük Aralık
103.50
105.04
Yıllık Aralık
81.22
118.26
Günlük Değişim
+2.09%
Aylık Değişim
+25.95%
6 Aylık Değişim
+1.88%
Yıllık Değişim
+10.18%
Önceki Kapanış
102.3 8
Open
103.5 4
Düşük
103.5 0
High
105.0 4
Hacim
1 766
Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler Temettüler
Çeyreklik Yıllık
  • Market Capitalization 11.66 B
  • Employee 11 K
  • Founded N/A
  • CEO Prahlad Singh
  • Website www.revvity.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000FXW512
  • Industry Tanı ve Araştırma
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
46.91
Fiyat/satışlar oranı
3.96
Hisse başına temettü
0.28
Temettü getirisi %
0.29

Revvity, Inc. Common Stock

Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines. In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY.

Haberler